TY  - JOUR
AU  - González-Salvatierra, Sheila
AU  - García-Fontana, Cristina
AU  - Andújar-Vera, Francisco
AU  - Grau-Perales, Alejandro Borja
AU  - Martínez-Heredia, Luis
AU  - Avilés-Pérez, María Dolores
AU  - Hayón-Ponce, María
AU  - Iglesias-Baena, Iván
AU  - Riquelme-Gallego, Blanca
AU  - Muñoz-Torres, Manuel
AU  - García-Fontana, Beatriz
PY  - 2021
DO  - 10.3390/jcm10102209
SN  - 2077-0383
UR  - https://hdl.handle.net/10668/26113
T2  - Journal of clinical medicine
AB  - Osteoglycin (OGN) could be a biomarker of mild kidney function impairment in type 2 diabetes (T2D). Our study aimed to determine the association between serum OGN and impaired kidney function risk in T2D patients and to analyze its potential role as...
LA  - en
KW  - biomarker
KW  - diabetic kidney disease
KW  - kidney function impairment
KW  - osteoglycin
KW  - type 2 diabetes
TI  - Osteoglycin as a Potential Biomarker of Mild Kidney Function Impairment in Type 2 Diabetes Patients.
TY  - research article
VL  - 10
ER  -